No summary available
1.25
hours
hours
Expired
Searching for Solutions
2025 Recertification Editorial Board Jade Abudia, PharmD, BCPP Augusta, GA No Relevant Financial Relationships to Disclose
AAPP Communities are where members can interact throughout the year to discuss issues, ask questions, and explore emerging trends. The new platform (2024) allows each member significant flexibility for how to engage with the AAPP Communities.
AAPP is working hard to standardize and improve clinical research through various initiatives and the awarding of this grant represents a significant milestone in the AAPP Outcomes Initiative. High quality research that supports the integration of psychiatric pharmacists into mental health care teams is critical for the advancement of the profession.
No summary available
New Learning Collaborative from SMI TTAC on July 15: Neurobiology and Recovery: Addressing Nicotine Use Among Individuals with Serious Mental Illness
We are cross promoting this event being held by the Smoking Cessation Leadership Center. They will dive into the neurobiology of nicotine addiction in individuals with serious mental illness (SMI), review promising evidence-based interventions and discuss how tobacco treatment can be effectively integrated into psychiatric and behavioral health systems. The session will support clinicians, public health professionals and behavioral health leaders in advancing tobacco-free recovery. CEUs are available for this event.
New Learning Collaborative from SMI TTAC on July 14: Co-Occurring SMI and SUD Learning Series | Session 3: Intersections of Methamphetamine-Induced Psychosis and Schizophrenia Spectrum Disorders
Methamphetamine-induced psychosis and schizophrenia spectrum disorders intersect in a complex clinical landscape. This webinar will deepen your understanding and improve treatment and care for people experiencing co-occurring serious mental illness (SMI) and stimulant use disorders. This session will be clinically focused. CEUs are not available for this event, but a certificate of attendance will be provided to attendees.
Trends in Past-month Cannabis Use Among Older Adults
In this cross-sectional study published in JAMA Internal Medicine, researchers analyzed data from the 2021-2023 National Survey on Drug Use and Health and found that past-month cannabis use among U.S. adults ages 65 and older rose from 4.8% to 7.0%. The greatest increases were among people with higher incomes, more education and chronic diseases and those living in states with legalized medical cannabis.
Trends in Suspected Fentanyl-involved Nonfatal Overdose Emergency Department Visits
In this Morbidity and Mortality Weekly Report (MMWR), emergency department (ED) data from October 2020 to March 2024 show that rates of suspected fentanyl-involved nonfatal overdose visits rose steadily across most demographic groups through mid-2023 before declining slightly. The increase highlights both the ongoing public health burden and the critical role of ED-based interventions.
Prescription Stimulant Use Disorder Among U.S. Adults Aged 18 to 64 Years
Using cross-sectional data from national surveys and prescription records between 2019 and 2022, this study found that among U.S. adults ages 18-64 who used prescription stimulants, 25.3% reported nonmedical use and 9.0% met criteria for prescription stimulant use disorder (PSUD), with highest prevalence linked to amphetamine use, highlighting the need for PSUD screening and treatment regardless of reported use patterns.
Cardiovascular Risk Associated With the Use of Cannabis and Cannabinoids
This systematic review and meta-analysis of real-world data connects cannabis use with an increased risk of major adverse cardiovascular events, including stroke (RR 1.20), acute coronary syndrome (RR 1.29) and cardiovascular death (RR 2.10), highlighting the need for routine screening of cannabis use in patients with serious cardiovascular conditions.
Nominations for AAPP Awards and Honors are Now Open!
Applications for AAPP Awards and Fellowship are now open! Nominate yourself, a colleague, mentor, and/or rising stars as we spotlight pharmacy excellence.
Featured Award: AAPP Advancing Patient Care Award Nominations Open
Help AAPP recognize excellence in patient care through your nomination for the Advancing Patient Care award recognizing individual member efforts and accomplishments in increasing patient access to high quality mental health care in exceptional and distinctive ways. Nominations close 10/1/2025.
Letter Urges Senate to Remove Higher Education Provisions from Big Beautiful Bill
AAPP joined 56 national organizations in urging Senators to support health professions education by preserving subsidized loans for undergraduates, retaining the Grad PLUS Program, and increasing the proposed aggregate limit for unsubsidized federal loans (for both undergraduate and graduate education).
Psychiatric learning experiences in PGY1 pharmacy residency training: A 5-year analysis
AAPP members Suzanne Harris, Jolene Bostwick, Marshall Cates, Amy Werremeyer and Charles Caley authored this article studying PLEs offered by postgraduate year 1 (PGY1) programs and completed by PGY1 residents over a 5-year period.
MHLG Medicaid Letter
This week, the Mental Health Liaison Group (MHLG) delivered a sign-on letter, led by AAPP and various MHLG leadership groups, to the Senate Finance and Budget committees, urging them to reject the House-passed changes to Medicaid within the budget reconciliation bill. MHLG is a coalition of national organizations representing consumers, family members, mental health and substance use care providers, advocates, payers and other stakeholders committed to strengthening Americans’ access to mental health and substance use care. The letter emphasizes that the proposed changes to the Medicaid program would harm individuals and families experiencing mental health and substance use challenges.
GAO Recommends CMS Target Behavioral Health Services in Prior Auth Audits
A new Government Accountability Office (GAO) report on the use of prior authorization (PA) for behavioral health services in Medicare Advantage (MA) found that of the 9 MA organizations reviewed, most required PA for inpatient and partial hospitalization care. Nearly all MA plans under review used internal coverage criteria for PA decisions, especially for inpatient care. GAO recommends that CMS target behavioral health services in its program audit reviews of PA denials and planned reviews of internal coverage criteria, scheduled to begin in 2026.
Rutgers Students Work to Reduce Mental Health Care Stigma After Incarceration
Rutgers students set out with a goal to reduce stigma associated with access to care after incarceration. With funding from an Impact Grant, students reviewed 29 applications from formerly incarcerated individuals with co-morbid mental illness and identified concerns of trust, autonomy, and provider interactions in the mental health care system. We applaud the Rutger Collegiate Chapter's fortitude to reach a niche population! Applications are now being accepted for 2025 Impact Grants. All AAPP Collegiate Chapters are encouraged to apply!
Incarnate Word Students Administer Vaccines and Utilize Mental Health Screening Tools
Recently, students at the Incarnate Word Feik School of Pharmacy (FSOP) AAPP Collegiate Chapter had the opportunity to interact with patients with Substance Use Disorders and to utilize screening tools. The AAPP Foundation is proud to have supported this project with an Impact Grant and looks forward to seeing the planned publication to encourage increased awareness on combining mental health and public health initiatives. The 2025 application portal is open! Learn more online.